---
figid: PMC2869521__cshperspect-NFK-000109_F4
figlink: /pmc/articles/PMC2869521/figure/A000109F4/
number: Figure 4
caption: Solid tumors activate the NF-κB pathway to maintain cell survival. (A) IKKε
  is frequently overexpressed in breast cancer in association with a gain or amplification
  of its genomic locus. IKKε phosphorylates a serine residue in CYLD, thereby lowering
  its deubiquitinase activity toward the IKKγ subunit, leading to a more active IKK
  enzyme. In addition, IKKε can directly phosphorylate serine-46 of IκBα. (B) Regulation
  of NF-κB by TBK1 downstream of mutant K-ras in lung cancer. Mutant K-ras signals
  to several downstream pathways, including the MAP kinase, PI(3) kinase, and RAL
  GTPase pathways. K-ras-associated RAL guanine nucleotide exchange factors (Ral-GEFs)
  promote the active, GTP-bound state of the RAL proteins. RalB interacts with Sec5,
  which in turn recruits TBK1, causing kinase activation. TBK1 triggers classical
  NF-κB pathway activation, as judged by the accumulation of nuclear p50/c-rel heterodimers.
  Because TBK1 can only phosphorylate one serine in IκBα, an as yet unknown kinase
  must cooperate with TBK1 to achieve dual IκBα phosphorylation.
pmcid: PMC2869521
papertitle: Oncogenic Activation of NF-κB.
reftext: Louis M. Staudt. Cold Spring Harb Perspect Biol. 2010 Jun;2(6):a000109.
pmc_ranked_result_index: '135409'
pathway_score: 0.9569199
filename: cshperspect-NFK-000109_F4.jpg
figtitle: Solid tumors activate the NFKB pathway to maintain cell survival
year: '2010'
organisms: Homo sapiens
ndex: 80ad638c-decd-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2869521__cshperspect-NFK-000109_F4.html
  '@type': Dataset
  description: Solid tumors activate the NF-κB pathway to maintain cell survival.
    (A) IKKε is frequently overexpressed in breast cancer in association with a gain
    or amplification of its genomic locus. IKKε phosphorylates a serine residue in
    CYLD, thereby lowering its deubiquitinase activity toward the IKKγ subunit, leading
    to a more active IKK enzyme. In addition, IKKε can directly phosphorylate serine-46
    of IκBα. (B) Regulation of NF-κB by TBK1 downstream of mutant K-ras in lung cancer.
    Mutant K-ras signals to several downstream pathways, including the MAP kinase,
    PI(3) kinase, and RAL GTPase pathways. K-ras-associated RAL guanine nucleotide
    exchange factors (Ral-GEFs) promote the active, GTP-bound state of the RAL proteins.
    RalB interacts with Sec5, which in turn recruits TBK1, causing kinase activation.
    TBK1 triggers classical NF-κB pathway activation, as judged by the accumulation
    of nuclear p50/c-rel heterodimers. Because TBK1 can only phosphorylate one serine
    in IκBα, an as yet unknown kinase must cooperate with TBK1 to achieve dual IκBα
    phosphorylation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NFKB1
  - MTOR
  - PIK3CG
  - IKBKE
  - IKBKG
  - PIK3R3
  - PIK3R5
  - PIK3CD
  - PIK3CB
  - PIK3CA
  - RALB
  - PIK3R6
  - IKBKB
  - BRAF
  - ARAF
  - PIK3R4
  - CHUK
  - TBK1
  - RAF1
  - REL
  - CYLD
  - Cancer
genes:
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PI(3)K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: IKKE
  symbol: IKKE
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKE
  entrez: '9641'
- word: IKKY
  symbol: IKK-gamma
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: PI(3)K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI(3)K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI(3)K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI(3)K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI(3)K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: RalB
  symbol: RALB
  source: hgnc_symbol
  hgnc_symbol: RALB
  entrez: '5899'
- word: PI(3)K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: IKKB
  symbol: IKK-beta
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: +RAF+
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: +RAF+
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: PI(3)K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: IKKA
  symbol: IKK-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: TBK1
  symbol: TBK1
  source: hgnc_symbol
  hgnc_symbol: TBK1
  entrez: '29110'
- word: +RAF+
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: c-rel
  symbol: c-Rel
  source: hgnc_alias_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: CYLD
  symbol: CYLD
  source: hgnc_symbol
  hgnc_symbol: CYLD
  entrez: '1540'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
